BioCentury | Jul 17, 2018
Product R&D

Natural spots

...suggesting those sites might be regulatory hotspots. The platform’s functional component uses natural language processing (NLP...
...Since HotSpot received seed funding before much of its platform technology was developed, including the NLP...
...told BioCentury HotSpot continuously sharpens its target prioritization at multiple steps in the platform. “The NLP...
BioCentury | Feb 4, 2010
Distillery Therapeutics

Indication: Cancer

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Ninein-like (NINL; NLP) Studies in...
...tumors, in cell culture and in mice suggest that inhibiting NINL could help treat cancer. NINL...
...78% of primary human breast and lung tumor samples. Almost all normal mice injected with Ninl-expressing...
Items per page:
1 - 2 of 2